Curative and suppressive treatment of P. falciparum malaria with oral and parenteral Fansidar.
D000208:Acute Disease; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002738:Chloroquine / Q000008:administration & dosage; D003622:Dapsone / Q000008:administration & dosage; D004338:Drug Combinations; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D008288:Malaria / Q000188:drug therapy*; D009073:Mozambique; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage; D011803:Quinine / Q000008:administration & dosage; D013413:Sulfadoxine; D013449:Sulfonamides / Q000008:administration & dosage*
D004338:Drug Combinations; D011743:Pyrimidines; D013449:Sulfonamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; D003622:Dapsone; D011803:Quinine; D011739:Pyrimethamine